SR

Sainath Reddy Manda

Active Director Director DIN 11001048
DIN 11001048 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sainath Reddy Manda

Data last updated:

Sainath Reddy Manda is a Director at Spikemed Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11001048
Primary Designation Director
Industry Pharma
First Appointment 13 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Spikemed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sainath Reddy Manda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sainath Reddy Manda

Sainath Reddy Manda currently holds 1 directorship: Spikemed Pharmaceuticals Private Limited (Director, since 13 Mar 2025).

Sainath Reddy Manda was first appointed on 13 Mar 2025 as Director at Spikemed Pharmaceuticals Private Limited.

The current boards of Sainath Reddy Manda's companies include Manga Bhavani (Spikemed Pharmaceuticals Private Limited), Praveen Kumar Belde (Spikemed Pharmaceuticals Private Limited), Sravanthi Simmula (Spikemed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available